Amneal Pharmaceuticals, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $6.68-$11.88 |
Market Cap | $3.6B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $2.9B |
Revenue Growth (YoY) | 11.7% |
Gross Profit (12 Mos) | $1B |
Diluted EPS | $0.01 |
News
See moreYahoo Finance • 9 days ago
Amneal raises 2025 EPS guidance and outlines $300M–$500M CREXONT sales target as portfolio expansion accelerates
Yahoo Finance • 10 days ago
Amneal Reports Third Quarter 2025 Financial Results
Yahoo Finance • 10 days ago
Here are the major earnings before the open Thursday
About
CEO | Mr. Chirag K. Patel |
CFO | Mr. Anastasios G. Konidaris |
Address | 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 8,300 |
